111 Investor Relations Material

111, Inc. operates as a digital healthcare platform in China, focusing on connecting patients with pharmaceutical products and healthcare services through both online and offline channels. The company operates in two main segments: B2C (business-to-consumer) and B2B (business-to-business). The B2C segment includes online retail of prescription and over-the-counter drugs, nutritional supplements, medical supplies, and personal care products. The B2B segment involves an online wholesale pharmacy platform that serves other pharmacies and healthcare providers. Additionally, 111, Inc. offers online consultation, electronic prescription services, and patient management services through its internet hospital. Headquartered in Shanghai, 111, Inc.'s shares are listed on the NASDAQ.